Jefferies Group LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Put Options

23 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Sep 21, 2023
BUY
$138.54 - $232.0 $8.52 Million - $14.3 Million
61,500 Added 191.59%
93,600 $18.7 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $8.52 Million - $14.3 Million
61,500 Added 191.59%
93,600 $18.7 Million
Q2 2022

Sep 21, 2023
BUY
$120.42 - $169.29 $1.51 Million - $2.12 Million
12,500 Added 63.78%
32,100 $4.68 Million
Q2 2022

Aug 15, 2022
BUY
$120.42 - $169.29 $1.51 Million - $2.12 Million
12,500 Added 63.78%
32,100 $4.68 Million
Q1 2022

Sep 21, 2023
SELL
$127.18 - $173.91 $4.4 Million - $6.02 Million
-34,600 Reduced 63.84%
19,600 $3.2 Million
Q1 2022

May 16, 2022
SELL
$127.18 - $173.91 $4.4 Million - $6.02 Million
-34,600 Reduced 63.84%
19,600 $3.2 Million
Q4 2021

Sep 21, 2023
BUY
$159.56 - $209.29 $4.79 Million - $6.28 Million
30,000 Added 123.97%
54,200 $9.19 Million
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $4.79 Million - $6.28 Million
30,000 Added 123.97%
54,200 $9.19 Million
Q3 2021

Sep 21, 2023
BUY
$169.75 - $207.73 $712,950 - $872,466
4,200 Added 21.0%
24,200 $4.57 Million
Q3 2021

Nov 15, 2021
BUY
$169.75 - $207.73 $712,950 - $872,466
4,200 Added 21.0%
24,200 $4.57 Million
Q2 2021

Sep 21, 2023
SELL
$128.63 - $176.89 $1.32 Million - $1.82 Million
-10,300 Reduced 33.99%
20,000 $3.39 Million
Q2 2021

Aug 20, 2021
SELL
$128.63 - $176.89 $255 Million - $350 Million
-1,980,000 Reduced 99.0%
20,000 $3.39 Million
Q2 2021

Aug 16, 2021
BUY
$128.63 - $176.89 $253 Million - $348 Million
1,969,700 Added 6500.66%
2,000,000 $3.39 Million
Q4 2020

Sep 21, 2023
SELL
$122.97 - $147.0 $7.78 Million - $9.31 Million
-63,300 Reduced 67.63%
30,300 $3.94 Million
Q4 2020

Feb 16, 2021
SELL
$122.97 - $147.0 $3.69 Million - $4.41 Million
-30,000 Reduced 49.75%
30,300 $3.94 Million
Q3 2020

Nov 13, 2020
BUY
$121.19 - $165.49 $36,357 - $49,647
300 Added 0.5%
60,300 $8.78 Million
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $4.19 Million - $6.03 Million
45,000 Added 300.0%
60,000 $6.53 Million
Q3 2019

Nov 13, 2019
BUY
$70.9 - $87.82 $1.06 Million - $1.32 Million
15,000 New
15,000 $1.21 Million
Q4 2018

Feb 14, 2019
SELL
$62.67 - $88.33 $614,166 - $865,634
-9,800 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$87.52 - $122.67 $3.13 Million - $4.39 Million
-35,800 Reduced 78.51%
9,800 $858,000
Q1 2018

May 15, 2018
BUY
$115.92 - $148.54 $69,552 - $89,124
600 Added 1.33%
45,600 $5.43 Million
Q4 2017

Feb 14, 2018
SELL
$114.49 - $139.98 $11 Million - $13.5 Million
-96,300 Reduced 68.15%
45,000 $5.72 Million
Q3 2017

Nov 14, 2017
BUY
$72.53 - $118.27 $10.2 Million - $16.7 Million
141,300
141,300 $16.6 Million

Others Institutions Holding ALNY

# of Institutions
641
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email